arrow
P

Pavel Dundr

general university hospital in prague
H指数:35
被引数:7,030

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunohistochemical expression of p53 is a helpful surrogate marker in the differential diagnosis of primary ovarian mucinous tumors: a large study of 181 cases of mucinous borderline tumor and carcinoma

p53免疫组化表达是原发性卵巢黏液性肿瘤鉴别诊断中有用的替代标志物:一项包含181例黏液性交界性肿瘤和癌的大样本研究

2026-09-230
PRE
CTNNB1-Driven Tumors of the Testis and Ovary: A Unifying Concept

CTNNB1驱动的睾丸和卵巢肿瘤:一种统一概念

2026-09-010
PRE
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial

早期宫颈癌女性患者前哨淋巴结活检而不进行系统性盆腔淋巴结清扫术: SENTIX前瞻性单臂非劣效性国际试验的最终结果

2025-07-040
PRE
The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas

罕见的妇科肉瘤研究: 379子宫肉瘤项目的分子和临床病理结果

2025-05-010
PRE
ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology

ISUOG/ESGO关于妇科肿瘤学中超声引导下活检的共识声明

2025-04-010
OAAI
Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study
2025-02-011
PRE
Correlation between p53 immunoexpression and TP53 mutation status in extrapulmonary small cell neuroendocrine carcinomas and its association with patient survival

肺外小细胞神经内分泌癌p53免疫表达与TP53突变状态的相关性及其与患者生存的关系

2025-01-230
OAAI
Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases

子宫肉瘤合并KAT6B/A::KANSL1融合: 9例分子和临床病理研究

2024-12-042
OAAI